Apollo Biowellness Inc (KOAN)
Apollo Biowellness Inc (KOAN) is a common stock listing on OTC Markets in the healthcare sector. The company describes its business as focused on regenerative medicine, with activity in the discovery, development, and marketing of products related to that field. Its stated areas include licensed, patent-pending natural stem cell mobilizing agents intended to support the body’s own stem cell mobilization process, as well as a licensed all-natural diet aid designed to help manage hunger through normal body signaling. Apollo Biowellness also says it conducts research and development on additional natural bioactive formulations, including secretogues aimed at supporting growth hormone production and related performance applications. The company is based in North Bergen, New Jersey.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-KOAN
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 17, 2026
|
—
|
—
|
—
|
216.596 K
|
—
|
—
|
—
|
—
|
—
|
—
|